Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Liver, Gallbladder & Pancreatic Health

Liver, Gallbladder & Pancreatic Health (105 Condition Guides)

Fatty liver disease (MASLD/MASH), viral hepatitis, cirrhosis, gallstones, and pancreatic disorders.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Liver, Gallbladder & Pancreatic Health Guides (105)

Clear Filter × Page 1 of 3

Acute cholecystitis

Acute cholecystitis (ICD-10-CM K81.0) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Acute cholecystitis with chronic cholecystitis

Acute cholecystitis with chronic cholecystitis (ICD-10-CM K81.2) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Acute pancreatitis with infected necrosis

Acute pancreatitis with infected necrosis (ICD-10-CM K85.92) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Acute pancreatitis without necrosis or infection

Acute pancreatitis without necrosis or infection (ICD-10-CM K85.90) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcohol induced acute pancreatitis with infected necrosis

Alcohol induced acute pancreatitis with infected necrosis (ICD-10-CM K85.22) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcohol-induced chronic pancreatitis

Alcohol-induced chronic pancreatitis (ICD-10-CM K86.0) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcoholic cirrhosis of liver without ascites

Alcoholic cirrhosis of liver without ascites (ICD-10-CM K70.30) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcoholic fatty liver

Alcoholic fatty liver (ICD-10-CM K70.0) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcoholic fibrosis and sclerosis of liver

Alcoholic fibrosis and sclerosis of liver (ICD-10-CM K70.2) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcoholic hepatitis with ascites

Alcoholic hepatitis with ascites (ICD-10-CM K70.11) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcoholic hepatitis without ascites

Alcoholic hepatitis without ascites (ICD-10-CM K70.10) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Alcoholic liver disease

Alcoholic liver disease (ICD-10-CM K70.9) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Autoimmune hepatitis

Autoimmune hepatitis (ICD-10-CM K75.4) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Bile Duct Diseases

Also called: Bilirubin • Bile • Gallbladder

Your liver makes a digestive juice called bile. Your gallbladder stores it between meals. When you eat, your gallbladder pushes the bile into tubes called bile ducts. They carry the bile to your small intestine. The bile helps break down fat. It also helps the liver get rid of toxins and wastes. Different diseases can block the bile ducts and cause a problem with the flow of bile: Gallstones, which can increase pressure in the gallbladder and cause a gallbladder attack. The pain usually lasts from one to several hours. Cancer Infections Birth defects, such as biliary atresia. It is the most common reason for liver transplants in children in the United States.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Biliary acute pancreatitis with infected necrosis

Biliary acute pancreatitis with infected necrosis (ICD-10-CM K85.12) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Biliary acute pancreatitis with uninfected necrosis

Biliary acute pancreatitis with uninfected necrosis—coded clinically as K85.11 across Liver & Hepatology guidelines—combines comprehensive hepatic panel [Biliary acute pancreatitis with uninfected necrosis K85.11] with structured follow-up of Total Bilirubin & in Biliary acute pancreatitis with uninfected necrosis (K85.11: Albumin) (Bilirubin 0.2–1.2 mg/dL; Albumin >= 4.0 g/dL (K85.11)).

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Biliary acute pancreatitis without necrosis or infection

Biliary acute pancreatitis without necrosis or infection (ICD-10-CM K85.10) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Biliary colic

Also called: Gallbladder • Biliary • Cholecystectomy

Biliary colic (ICD-10-CM K80.50) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of bile duct with acute and chronic cholangitis with obstruction

Calculus of bile duct with acute and chronic cholangitis with obstruction—coded clinically as K80.37 across Liver & Hepatology guidelines—combines comprehensive hepatic panel [Calculus of bile duct with acute and chronic cholangitis with obstruction K80.37] with structured follow-up of Total Bilirubin & in Calculus of bile duct with acute and chronic cholangitis with obstruction (K80.37: Albumin) (Bilirubin 0.2–1.2 mg/dL; Albumin >= 4.0 g/dL (K80.37)).

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of bile duct with acute and chronic cholangitis without obstruction

Calculus of bile duct with acute and chronic cholangitis without obstruction (ICD-10-CM K80.36) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of bile duct with acute and chronic cholecystitis without obstruction

Designated in federal medical registries as K80.46, Calculus of bile duct with acute and chronic cholecystitis without obstruction falls under Liver & Hepatology management, where biliary/pancreatic ductal imaging [Calculus of bile duct with acute and chronic cholecystitis without obstruction K80.46] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of gallbladder and bile duct with acute cholecystitis without obstruction

Calculus of gallbladder and bile duct with acute cholecystitis without obstruction (ICD-10-CM K80.62) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of gallbladder and bile duct without cholecystitis without obstruction

Calculus of gallbladder and bile duct without cholecystitis without obstruction (ICD-10-CM K80.70) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of gallbladder with acute and chronic cholecystitis with obstruction

Calculus of gallbladder with acute and chronic cholecystitis with obstruction (ICD-10-CM K80.13) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of gallbladder with acute and chronic cholecystitis without obstruction

Calculus of gallbladder with acute and chronic cholecystitis without obstruction (ICD-10-CM K80.12) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Calculus of gallbladder with acute cholecystitis without obstruction

Calculus of gallbladder with acute cholecystitis without obstruction—coded clinically as K80.00 across Liver & Hepatology guidelines—combines hepatotoxic medication audit [Calculus of gallbladder with acute cholecystitis without obstruction K80.00] with structured follow-up of Total Bilirubin & in Calculus of gallbladder with acute cholecystitis without obstruction (K80.00: Albumin) (Bilirubin 0.2–1.2 mg/dL; Albumin >= 4.0 g/dL (K80.00)).

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Central hemorrhagic necrosis of liver

Central hemorrhagic necrosis of liver (ICD-10-CM K76.2) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Liver, Gallbladder & Pancreatic Health on dotMD.com?

dotMD.com maps Liver, Gallbladder & Pancreatic Health against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Liver, Gallbladder & Pancreatic Health visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee